Unlocking Cardiovascular Potential: Presenting the Latest Evidence Supporting Positive Outcomes with GLP-1s

Time: 9:00 am
day: Conference Day One


  • Exploring evidence supporting positive cardiovascular outcomes of GLP-1s to reveal the possibility of a cardiovascular market for therapies
  • Considering approaches, including the use of agonist combinations, to gain positive cardiovascular outcomes
  • Navigating potential challenges that may arise in the context of employing GLP-1 treatments for cardiovascular indications